FDA Inspection 1313102 — Waiss Investing LLC
The FDA completed an inspection of Waiss Investing LLC on Apr 2, 2026 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Tobacco.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 2, 2026
- Fiscal Year
- 2026
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Las Vegas, NV (United States)